Why Diversity in Trials Is Doomed Until We Fix Reimbursement with Sam Whitaker
In this episode of 'Trials with Maya Z', host Maya Z interviews Sam Whitaker from Mural Health, discussing the pressing issue of patient reimbursement in clinical trials.
Sam Whitaker is a Founder and CEO of Mural Health, a tech company on a mission to make it easy to participate in clinical research. Mural Health was founded in 2022 as Sam’s effort to evolve the product he invented, the ClinCard, when he founded Greenphire in 2008.
Maya and Sam explore how one-third of Americans are excluded from participating in clinical trials due to financial constraints and eligibility for welfare programs. The dialogue highlights the need for the clinical research industry to address financial barriers. Here are the topics Maya and Sam deep dive into:
01:03 Introducing Sam Whitaker: The Man Behind a Great Mission
03:01 The Reimbursement Dilemma: How It Affects Patient Diversity in Clinical Trials
20:30 Exploring Solutions: Legislative Efforts and Centralized Reimbursement Models
31:15 Empowering Change: How You Can Support and The Ideal World for Clinical Trials
Sign the letter to Congress and support Sam’s mission.
Tune in today for a thrilling journey into the world of clinical trials – expand your knowledge!
Maya Zlatanova, CEO of Trialhub
Sam Whitaker, CEO of Mural Health
See More:
